Sage Journals: Discover world-class research

Open access

Research article

First published 2025-5

Prevalence and clinicopathological features of human epidermal growth factor receptor-2–low breast cancers: A single-center experience

ılkay Cinar

Journal of International Medical Research

Open access

Research article

First published 2023

Cost-effectiveness of trastuzumab deruxtecan in previously treated human epidermal growth factor receptor 2-low metastatic breast cancer

Jiangping Yang, Jiaqi Han, Ni Zeng [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Human Epidermal Growth Factor Receptor 2-Low Breast Cancer: Prevalence Rate and Scoring Concordance Among Pathologists

Maher Sughayer, Ghada Al-Jussani, Ahmed Salem [...]

Breast Cancer: Basic and Clinical Research

Open access

Research article

First published 2024

Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer

Anna Pous, Adrià Bernat-Peguera, Assumpció López-Paradís [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2023

The HER2-low revolution in breast oncology: steps forward and emerging challenges

Eleonora Nicolò, Luca Boscolo Bielo, Giuseppe Curigliano [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Antibody–drug conjugates in patients with advanced/metastatic HER2-low-expressing breast cancer: a systematic review and meta-analysis

Isabella Michelon, Maria Inez Dacoregio, Maysa Vilbert [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2017-3

HR+HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells

Krisha Desai, Radhika Aiyappa, Jyothi S Prabhu [...]

Tumor Biology

Retricted access

Research article

First published 2018-1

Specific targeting of human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer cells by polyethylene glycol-grafted polyethyleneimine modified with anti-HER2 single-domain antibody

Batoul Saqafi, Fatemeh Rahbarizadeh

Journal of Bioactive and Compatible Polymers

Open access

Research article

First published 2026

Evaluation of RC48-ADC in Combination with PRaG Regimen: An Open-Label,Prospective,Multicentre Study Assessing Efficacy and Safety for Advanced Refractory HER2-Expressing Solid Tumors (PRaG3.0 Study Protocol)

Meiling Xu, Yuehong Kong, Junjun Zhang [...]

Technology in Cancer Research & Treatment

Open access

Review article

First published 2023

Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm

Charlie Yang, Christine Brezden-Masley, Anil Abraham Joy [...]

Therapeutic Advances in Medical Oncology

Search results